Abstract
Targeted drug delivery and controllable generation of oxygen-independent toxic free radicals in tumor hypoxia environments are of great importance in cancer therapy. Here, a thermoresponsive nanoplatform was introduced by modifying carbon-coated iron carbide (Fe5C2) nanoparticles with bovine serum albumin (BSA) to achieve better water solubility and biocompatibility. Then a type of polymerization initiator (AIPH) was effectively loaded on the surface of Fe5C2–BSA nanoparticles and sealed by a phase change material (PCM) for higher drug loading and controlled drug release stimulated by heat. Upon illumination by near-infrared light, the photothermal effect of Fe5C2 nanoparticles melts the PCM, triggering the release of encapsulated AIPH to produce free radicals, which effectively kill the hypoxia cancer cells. Additionally, the special magnetic performance enables targeted and tracked therapy under the driving of an external magnetic field. What’s more, the as-prepared multifunctional theranostic nanoplatf...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.